Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are:
- Brevinor - norethisterone 0.5 mg and ethinylestradiol 35 micrograms
- Norimin - norethisterone 0.5 mg and ethinylestradiol 35 micrograms
- Brevinor-1 - norethisterone 1 mg and ethinylestradiol 35 micrograms
- Norimin-1 - norethisterone 1 mg and ethinylestradiol 35 micrograms.
All four products are sponsored by Pfizer Australia Pty Ltd.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
